Selected research
Industry Research
Qi-Tonifying Chinese Medicine Injections Industry Research Report 2026
Market perspective
The global Qi-Tonifying Chinese Medicine Injections market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Qi-Tonifying Chinese Medicine Injections is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Qi-Tonifying Chinese Medicine Injections is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Qi-Tonifying Chinese Medicine Injections is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Qi-Tonifying Chinese Medicine Injections include Chiatai Qingchunbao Pharmaceutical, ZBD Pharmaceutical, Jilin Jian Yisheng Pharmaceutical, Suzhong Pharmaceutical Group, Shineway Pharmaceutical, China Resources Sanjiu, Sinopharm Yibin Pharmaceutical, Dali Pharmaceutical and Changshu Leiyunshang Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Qi-Tonifying Chinese Medicine Injections market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Qi-Tonifying Chinese Medicine Injections Market by Company
Chiatai Qingchunbao Pharmaceutical
ZBD Pharmaceutical
Jilin Jian Yisheng Pharmaceutical
Suzhong Pharmaceutical Group
Shineway Pharmaceutical
China Resources Sanjiu
Sinopharm Yibin Pharmaceutical
Dali Pharmaceutical
Changshu Leiyunshang Pharmaceutical
Qi-Tonifying Chinese Medicine Injections Segment by Type
Shengmai Injection
Astragalus Injection
Other
Qi-Tonifying Chinese Medicine Injections Segment by Application
Secondary Hospital
Tertiary Hospital
Other
Qi-Tonifying Chinese Medicine Injections Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Qi-Tonifying Chinese Medicine Injections market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Qi-Tonifying Chinese Medicine Injections and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Qi-Tonifying Chinese Medicine Injections.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Qi-Tonifying Chinese Medicine Injections manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Qi-Tonifying Chinese Medicine Injections by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Qi-Tonifying Chinese Medicine Injections in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Shengmai Injection
- Astragalus Injection
- Other
Applications
- Secondary Hospital
- Tertiary Hospital
- Other
Companies covered
- Chiatai Qingchunbao Pharmaceutical
- ZBD Pharmaceutical
- Jilin Jian Yisheng Pharmaceutical
- Suzhong Pharmaceutical Group
- Shineway Pharmaceutical
- China Resources Sanjiu
- Sinopharm Yibin Pharmaceutical
- Dali Pharmaceutical
- Changshu Leiyunshang Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Qi-Tonifying Chinese Medicine Injections Market Size (2021-2032)
- 2.2.2 Global Qi-Tonifying Chinese Medicine Injections Sales (2021-2032)
- 2.2.3 Global Qi-Tonifying Chinese Medicine Injections Market Average Price (2021-2032)
- 2.3 Qi-Tonifying Chinese Medicine Injections by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Shengmai Injection
- 2.3.3 Astragalus Injection
- 2.3.4 Other
- 2.4 Qi-Tonifying Chinese Medicine Injections by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Secondary Hospital
- 2.4.3 Tertiary Hospital
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Qi-Tonifying Chinese Medicine Injections Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Qi-Tonifying Chinese Medicine Injections Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Qi-Tonifying Chinese Medicine Injections Revenue of Manufacturers (2021-2026)
- 3.4 Global Qi-Tonifying Chinese Medicine Injections Average Price by Manufacturers (2021-2026)
- 3.5 Global Qi-Tonifying Chinese Medicine Injections Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Qi-Tonifying Chinese Medicine Injections, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Qi-Tonifying Chinese Medicine Injections, Product Type & Application
- 3.8 Global Manufacturers of Qi-Tonifying Chinese Medicine Injections, Established Date
- 3.9 Global Qi-Tonifying Chinese Medicine Injections Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Chiatai Qingchunbao Pharmaceutical
- 4.1.1 Chiatai Qingchunbao Pharmaceutical Company Information
- 4.1.2 Chiatai Qingchunbao Pharmaceutical Business Overview
- 4.1.3 Chiatai Qingchunbao Pharmaceutical Qi-Tonifying Chinese Medicine Injections Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Chiatai Qingchunbao Pharmaceutical Qi-Tonifying Chinese Medicine Injections Product Portfolio
- 4.1.5 Chiatai Qingchunbao Pharmaceutical Recent Developments
- 4.2 ZBD Pharmaceutical
- 4.2.1 ZBD Pharmaceutical Company Information
- 4.2.2 ZBD Pharmaceutical Business Overview
- 4.2.3 ZBD Pharmaceutical Qi-Tonifying Chinese Medicine Injections Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 ZBD Pharmaceutical Qi-Tonifying Chinese Medicine Injections Product Portfolio
- 4.2.5 ZBD Pharmaceutical Recent Developments
- 4.3 Jilin Jian Yisheng Pharmaceutical
- 4.3.1 Jilin Jian Yisheng Pharmaceutical Company Information
- 4.3.2 Jilin Jian Yisheng Pharmaceutical Business Overview
- 4.3.3 Jilin Jian Yisheng Pharmaceutical Qi-Tonifying Chinese Medicine Injections Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Jilin Jian Yisheng Pharmaceutical Qi-Tonifying Chinese Medicine Injections Product Portfolio
- 4.3.5 Jilin Jian Yisheng Pharmaceutical Recent Developments
- 4.4 Suzhong Pharmaceutical Group
- 4.4.1 Suzhong Pharmaceutical Group Company Information
- 4.4.2 Suzhong Pharmaceutical Group Business Overview
- 4.4.3 Suzhong Pharmaceutical Group Qi-Tonifying Chinese Medicine Injections Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Suzhong Pharmaceutical Group Qi-Tonifying Chinese Medicine Injections Product Portfolio
- 4.4.5 Suzhong Pharmaceutical Group Recent Developments
- 4.5 Shineway Pharmaceutical
- 4.5.1 Shineway Pharmaceutical Company Information
- 4.5.2 Shineway Pharmaceutical Business Overview
- 4.5.3 Shineway Pharmaceutical Qi-Tonifying Chinese Medicine Injections Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Shineway Pharmaceutical Qi-Tonifying Chinese Medicine Injections Product Portfolio
- 4.5.5 Shineway Pharmaceutical Recent Developments
- 4.6 China Resources Sanjiu
- 4.6.1 China Resources Sanjiu Company Information
- 4.6.2 China Resources Sanjiu Business Overview
- 4.6.3 China Resources Sanjiu Qi-Tonifying Chinese Medicine Injections Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 China Resources Sanjiu Qi-Tonifying Chinese Medicine Injections Product Portfolio
- 4.6.5 China Resources Sanjiu Recent Developments
- 4.7 Sinopharm Yibin Pharmaceutical
- 4.7.1 Sinopharm Yibin Pharmaceutical Company Information
- 4.7.2 Sinopharm Yibin Pharmaceutical Business Overview
- 4.7.3 Sinopharm Yibin Pharmaceutical Qi-Tonifying Chinese Medicine Injections Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Sinopharm Yibin Pharmaceutical Qi-Tonifying Chinese Medicine Injections Product Portfolio
- 4.7.5 Sinopharm Yibin Pharmaceutical Recent Developments
- 4.8 Dali Pharmaceutical
- 4.8.1 Dali Pharmaceutical Company Information
- 4.8.2 Dali Pharmaceutical Business Overview
- 4.8.3 Dali Pharmaceutical Qi-Tonifying Chinese Medicine Injections Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Dali Pharmaceutical Qi-Tonifying Chinese Medicine Injections Product Portfolio
- 4.8.5 Dali Pharmaceutical Recent Developments
- 4.9 Changshu Leiyunshang Pharmaceutical
- 4.9.1 Changshu Leiyunshang Pharmaceutical Company Information
- 4.9.2 Changshu Leiyunshang Pharmaceutical Business Overview
- 4.9.3 Changshu Leiyunshang Pharmaceutical Qi-Tonifying Chinese Medicine Injections Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Changshu Leiyunshang Pharmaceutical Qi-Tonifying Chinese Medicine Injections Product Portfolio
- 4.9.5 Changshu Leiyunshang Pharmaceutical Recent Developments
5 Global Qi-Tonifying Chinese Medicine Injections Market Scenario by Region
- 5.1 Global Qi-Tonifying Chinese Medicine Injections Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Qi-Tonifying Chinese Medicine Injections Sales by Region: 2021-2032
- 5.2.1 Global Qi-Tonifying Chinese Medicine Injections Sales by Region: 2021-2026
- 5.2.2 Global Qi-Tonifying Chinese Medicine Injections Sales by Region: 2027-2032
- 5.3 Global Qi-Tonifying Chinese Medicine Injections Revenue by Region: 2021-2032
- 5.3.1 Global Qi-Tonifying Chinese Medicine Injections Revenue by Region: 2021-2026
- 5.3.2 Global Qi-Tonifying Chinese Medicine Injections Revenue by Region: 2027-2032
- 5.4 North America Qi-Tonifying Chinese Medicine Injections Market Facts & Figures by Country
- 5.4.1 North America Qi-Tonifying Chinese Medicine Injections Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Qi-Tonifying Chinese Medicine Injections Sales by Country (2021-2032)
- 5.4.3 North America Qi-Tonifying Chinese Medicine Injections Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Qi-Tonifying Chinese Medicine Injections Market Facts & Figures by Country
- 5.5.1 Europe Qi-Tonifying Chinese Medicine Injections Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Qi-Tonifying Chinese Medicine Injections Sales by Country (2021-2032)
- 5.5.3 Europe Qi-Tonifying Chinese Medicine Injections Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Qi-Tonifying Chinese Medicine Injections Market Facts & Figures by Country
- 5.6.1 Asia Pacific Qi-Tonifying Chinese Medicine Injections Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Qi-Tonifying Chinese Medicine Injections Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Qi-Tonifying Chinese Medicine Injections Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Qi-Tonifying Chinese Medicine Injections Market Facts & Figures by Country
- 5.7.1 South America Qi-Tonifying Chinese Medicine Injections Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Qi-Tonifying Chinese Medicine Injections Sales by Country (2021-2032)
- 5.7.3 South America Qi-Tonifying Chinese Medicine Injections Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Qi-Tonifying Chinese Medicine Injections Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Qi-Tonifying Chinese Medicine Injections Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Qi-Tonifying Chinese Medicine Injections Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Qi-Tonifying Chinese Medicine Injections Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Qi-Tonifying Chinese Medicine Injections Sales by Type (2021-2032)
- 6.1.1 Global Qi-Tonifying Chinese Medicine Injections Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Qi-Tonifying Chinese Medicine Injections Sales Market Share by Type (2021-2032)
- 6.2 Global Qi-Tonifying Chinese Medicine Injections Revenue by Type (2021-2032)
- 6.2.1 Global Qi-Tonifying Chinese Medicine Injections Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Qi-Tonifying Chinese Medicine Injections Revenue Market Share by Type (2021-2032)
- 6.3 Global Qi-Tonifying Chinese Medicine Injections Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Qi-Tonifying Chinese Medicine Injections Sales by Application (2021-2032)
- 7.1.1 Global Qi-Tonifying Chinese Medicine Injections Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Qi-Tonifying Chinese Medicine Injections Sales Market Share by Application (2021-2032)
- 7.2 Global Qi-Tonifying Chinese Medicine Injections Revenue by Application (2021-2032)
- 7.2.1 Global Qi-Tonifying Chinese Medicine Injections Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Qi-Tonifying Chinese Medicine Injections Revenue Market Share by Application (2021-2032)
- 7.3 Global Qi-Tonifying Chinese Medicine Injections Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Qi-Tonifying Chinese Medicine Injections Value Chain Analysis
- 8.1.1 Qi-Tonifying Chinese Medicine Injections Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Qi-Tonifying Chinese Medicine Injections Production Mode & Process
- 8.2 Qi-Tonifying Chinese Medicine Injections Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Qi-Tonifying Chinese Medicine Injections Distributors
- 8.2.3 Qi-Tonifying Chinese Medicine Injections Customers
9 Global Qi-Tonifying Chinese Medicine Injections Analyzing Market Dynamics
- 9.1 Qi-Tonifying Chinese Medicine Injections Industry Trends
- 9.2 Qi-Tonifying Chinese Medicine Injections Industry Drivers
- 9.3 Qi-Tonifying Chinese Medicine Injections Industry Opportunities and Challenges
- 9.4 Qi-Tonifying Chinese Medicine Injections Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst